Dudediligence.

Corbus Pharmaceuticals Holdings, Inc

CRBPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$13.8MSep ’24−$9.5MDec ’24−$17.0MMar ’25−$17.7MJun ’25−$23.3MSep ’25−$20.6MDec ’25−$23.0MMar ’26−$35.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$881,705$0.00none on filenone on filenone on file
Operating income−$56.0M−$39.8M−$45.1M−$48.7M−$85.3M
Net income−$45.6M−$42.3M−$44.6M−$40.2M−$78.5M
Operating cash flow−$48.2M−$37.5M−$36.1M−$41.8M−$64.5M
Free cash flow−$48.2M−$37.6M−$36.1M−$41.8M−$64.5M
Cash$25.0M$17.0M$13.7M$17.2M$28.5M
Debt$18.7M$18.8M$0.00none on filenone on file
Shares outstanding4.2M4.2M4.4M12.2M17.6M